Understanding ATP2B1: Potential Drug Target and Biomarker (G490)

Target Name: ATP2B1

NCBI ID: G490

ATP2B1

Understanding ATP2B1: Potential Drug Target and Biomarker

ATP2B1 is a protein that plays a crucial role in the regulation of calcium homeostasis in various cell types. It is a member of the ATP-binding cassette (ABC) family, which is a subfamily of transmembrane proteins that mediate intracellular signaling. ATP2B1 is expressed in many different tissues and is involved in various cellular processes, including intracellular signaling, neurotransmission, and muscle contractions.

Despite its importance, little is known about ATP2B1. There are only a few studies that have investigated its function, and these studies have provided limited information about its potential as a drug target or biomarker.

The Importance of ATP2B1

ATP2B1 is involved in the regulation of calcium homeostasis, which is the maintaining of a stable levels of calcium in the cell. Calcium is essential for many cellular processes, including muscle contractions, nerve signaling, and cell signaling. It also plays a role in intracellular signaling and is involved in the regulation of many different cellular processes.

ATP2B1 is involved in the regulation of calcium homeostasis by ATP. It is a cofactor of the protein ATP-binding cassette (APC), which is a subfamily of transmembrane proteins that mediate intracellular signaling. APC is composed of several different subunits, including ATP2B1, which is responsible for regulating the ATP-dependent translocation of calcium ions into the cytosol.

ATP2B1 is also involved in the regulation of calcium homeostasis by changes in the level of its own activity. It is known to be regulated by various factors, including changes in the level of its own ATPase activity and changes in the level of its own calcium ions.

Potential Drug Target

The potential drug target for ATP2B1 is related to its role in the regulation of calcium homeostasis. Calcium ions are involved in many different cellular processes, including muscle contractions, nerve signaling, and intracellular signaling. They are also involved in the regulation of many different cellular processes, including cell signaling, inflammation, and neurotransmission.

Drugs that target ATP2B1 have the potential to interfere with its ability to regulate calcium homeostasis. This could lead to changes in the level of calcium ions in the cell, which could have a variety of different effects on cellular processes.

Biomarker

ATP2B1 may also be a useful biomarker for some diseases. The regulation of calcium homeostasis is involved in many different cellular processes, including muscle contractions, nerve signaling, and intracellular signaling. As such, changes in the level of calcium ions in the cell could be an indicator of certain diseases.

For example, changes in the level of calcium ions in the cell could be an indicator of hypocalcemia, which is a condition in which the level of calcium ions in the cell is too low. Hypocalcemia can be caused by a variety of different factors, including inadequate intake of calcium, certain medications, or certain diseases.

In addition to its potential as a drug target, ATP2B1 may also be a useful biomarker for some diseases. Changes in the level of calcium ions in the cell can be an indicator of certain diseases, including hypocalcemia, hypercalcemia, and myocardial infarction.

Conclusion

ATP2B1 is a protein that plays a crucial role in the regulation of calcium homeostasis in various cell types. Its importance to cellular processes is emphasized by its involvement in the regulation of ATP-dependent translocation of calcium ions into the cytosol. Despite its importance, little is known about its function, and there are only a few studies that have investigated its potential as a drug target or biomarker. Further research is needed to fully understand the role of ATP2B1 in cellular processes and its potential as a drug target or biomarker.

Protein Name: ATPase Plasma Membrane Ca2+ Transporting 1

Functions: Catalyzes the hydrolysis of ATP coupled with the transport of calcium from the cytoplasm to the extracellular space thereby maintaining intracellular calcium homeostasis (PubMed:35358416). Plays a role in blood pressure regulation through regulation of intracellular calcium concentration and nitric oxide production leading to regulation of vascular smooth muscle cells vasoconstriction. Positively regulates bone mineralization through absorption of calcium from the intestine. Plays dual roles in osteoclast differentiation and survival by regulating RANKL-induced calcium oscillations in preosteoclasts and mediating calcium extrusion in mature osteoclasts (By similarity). Regulates insulin sensitivity through calcium/calmodulin signaling pathway by regulating AKT1 activation and NOS3 activation in endothelial cells (PubMed:29104511). May play a role in synaptic transmission by modulating calcium and proton dynamics at the synaptic vesicles

The "ATP2B1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ATP2B1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets